The European Medicines Agency has said the AstraZeneca vaccine does not increase the risk of thromboembolic events but it cannot rule out a link with a rare cases of cerebral vein/cerebral venous sinus thrombosis. Based on vaccine safety surveillance reports from countries such as Germany, the EMA statement said cases of thrombosis and thrombocytopenia, some ...
EMA says cerebral vein sinus thrombosis cases may be linked to AstraZeneca vaccine
By Michael Woodhead
19 Mar 2021